Atlas Trials

Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM)

Clinical trial NCT01724606 · COMPLETED

Trial details

NCT number
NCT01724606
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast CancerBrain Metastases
Start date
2012-11-05
Primary completion
2022-03-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.